382 related articles for article (PubMed ID: 9056422)
1. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
Guvakova MA; Surmacz E
Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
[TBL] [Abstract][Full Text] [Related]
2. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
[TBL] [Abstract][Full Text] [Related]
3. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
4. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype.
Pennisi PA; Barr V; Nunez NP; Stannard B; Le Roith D
Cancer Res; 2002 Nov; 62(22):6529-37. PubMed ID: 12438247
[TBL] [Abstract][Full Text] [Related]
6. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D
J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722
[TBL] [Abstract][Full Text] [Related]
7. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
Arteaga CL; Osborne CK
Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.
Shen WH; Zhou JH; Broussard SR; Freund GG; Dantzer R; Kelley KW
Cancer Res; 2002 Aug; 62(16):4746-56. PubMed ID: 12183434
[TBL] [Abstract][Full Text] [Related]
11. An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer.
Mamay CL; Mingo-Sion AM; Wolf DM; Molina MD; Van Den Berg CL
Oncogene; 2003 Jan; 22(4):602-14. PubMed ID: 12555073
[TBL] [Abstract][Full Text] [Related]
12. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC
Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.
Parisot JP; Hu XF; DeLuise M; Zalcberg JR
Br J Cancer; 1999 Feb; 79(5-6):693-700. PubMed ID: 10070856
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
16. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
18. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
[TBL] [Abstract][Full Text] [Related]
19. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.
Surmacz E; Burgaud JL
Clin Cancer Res; 1995 Nov; 1(11):1429-36. PubMed ID: 9815941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
